Inventor · disambiguated record
Elisabeth Hennessy
Also filed as: HENNESSY ELISABETH · HENNESSY ELISABETH T · HENNESSY ELISABETH THERESE
8 granted patents·8 pending applications·18 citations·filing 2014–2023
81Inventor score
Top patents by PatentIndex Score
16 records- 0193US11697657B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2020·Granted Jul 11, 2023·4 cites·22 claims
- 0288US11312719B29-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME·Filed 2019·Granted Apr 26, 2022·4 cites·25 claims
- 0388US9487472B2Synthesis of acyclic and cyclic amines using iron-catalyzed nitrene group transferHARVARD COLLEGE·Filed 2014·Granted Nov 8, 2016·6 cites·16 claims
- 0484US9724682B2Synthesis of acyclic and cyclic amines using iron-catalyzed nitrene group transferHARVARD COLLEGE·Filed 2016·Granted Aug 8, 2017·2 cites·20 claims
- 0581US12297208B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2023·Granted May 13, 2025·0 cites·18 claims
- 0681US12291538B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2023·Granted May 6, 2025·0 cites·6 claims
- 0781US12263171B27-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 1, 2025·2 cites·20 claims
- 0871US12060357B29-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2022·Granted Aug 13, 2024·0 cites·28 claims
- 0959US2025171447A1Adenosine receptor antagonists, pharmaceutical compositions and their use thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1056US2024262842A1Small molecule inhibitors of kras g12c mutantMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1156US2024246968A1Small molecule inhibitors of kras g12c mutantMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1254US2024076297A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 1354US2024239788A1Small molecule inhibitors of kras g12d mutantMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1453US2024417408A1Small molecule inhibitors of kras g12c mutantMERCK SHARP & DOHME·Filed 2022·Application pending·0 cites
- 1552US2024124478A1SPIROCYCLIC-SUBSTITUTED 6,7-DIHYDRO-PYRANO[2,3-d]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANTMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 1651US2023416266A16,7-DIHYDRO-PYRANO[2,3-d]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANTMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elisabeth Hennessy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →